344
Participants
Start Date
June 30, 2008
Primary Completion Date
September 30, 2009
Study Completion Date
January 31, 2011
S-1 & Oxaliplatin
S-1 and Oxaliplatin : S-1 80 mg/m2/day, D1-14 Oxaliplatin, 130 mg/m2/day, D1 Repeated every 3 weeks
Capecitabine & Oxaliplatin
COX : Capecitabine 1000 mg/m2/day, D1-14 Oxaliplatin, 130 mg/m2/day, D1 Repeated every 3 weeks
National Cancer Center, Goyang-si
Seoul National University Bundang Hospital, Seongnam-si
Gachon University Gil Medical Center, Inchon
Seoul National University Hospital, Seoul
Yonsei University, Seoul
Chonnam National University Hospital, Hwasun
Yeungnam University, Daegu
Samsung Medical Center, Seoul
Asan Medical Center, Seoul
Korea Cancer Center Hospital, Seoul
Soon Chun Hyang University Hospital, Seoul
Collaborators (1)
National Cancer Center, Korea
OTHER_GOV
Seoul National University Bundang Hospital
OTHER
Seoul National University Hospital
OTHER
Gachon University Gil Medical Center
OTHER
Yonsei University
OTHER
Asan Medical Center
OTHER
Chonnam National University Hospital
OTHER
Samsung Medical Center
OTHER